Crescent Capital BDC, Inc.
Crescent Capital BDC is a specialty finance company that lends to middle-market companies, primarily private U.S. businesses. It invests in secured and unsecured debt, including first-lien, unitranche, second-lien, mezzanine and subordinated debt, as well as related equity securities. Its investments can be originated directly as private credit transactions or purchased in primary and secondary markets for broadly syndicated loans and bonds. Borrowers use its capital for growth, acquisitions, expansion and recapitalizations. Crescent Capital BDC generates income primarily from interest on debt investments, dividends on direct equity investments, gains from sales of debt and equity securities, and loan origination and other fees. The company is managed by Crescent Cap Advisors, with administrative services provided by CCAP Administration. Crescent, the investment manager affiliated with its adviser, is headquartered in Los Angeles.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CCAP in the last 30 days.
See all $CCAP insider activity →Crescent Capital BDC (CCAP) declared a quarterly dividend of $0.34 per share, maintaining the prior rate, and a special dividend of $0.03 per share. The forward yield is 14.72%. The quarterly dividend is payable January 15, with a record date of December 31, while the special dividend is payable December 15.
Crescent Capital BDC (CCAP) reported Q3 2026 net investment income of $0.37 per share, net income of $0.27 per share, and NAV of $17.72 per share. The company declared a $0.34 dividend for Q4 and authorized $50M in share repurchases.
Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ
Over the past 7 days, AlphAI's AI scored 7 news stories mentioning CCAP (Crescent Capital BDC, Inc.). Coverage has skewed bullish: 6 bullish, 1 neutral, and 0 bearish.
Recent CCAP coverage spans insider activity, earnings and financial news.
The dividend announcement provides a modest income boost and may attract yield‑seeking investors.
Earnings-style update with dividend declaration and buyback authorization likely supports near-term downside protection, but investors will focus on NAV and portfolio performance details in the filing.
Dividend declaration and buyback authorization, alongside Q3 NAV and earnings per share figures, can shift near-term income and discount-rate expectations for CCAP.
The announcement sets the timing for the earnings release, likely prompting modest pre‑announcement positioning.
Downgrade could trigger a short-term dip.
AlphAI scores every news story that mentions CCAP with an AI model for sentiment and relevance, and aggregates insider trades from Crescent Capital BDC, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Crescent Capital BDC (CCAP) declared a quarterly dividend of $0.34 per share, maintaining the prior rate, and a special dividend of $0.03 per share. The forward yield is 14.72%. The quarterly dividend is payable January 15, with a record date of December 31, while the special dividend is payable December 15.
Crescent Capital BDC (CCAP) reported Q3 2026 net investment income of $0.37 per share, net income of $0.27 per share, and NAV of $17.72 per share. The company declared a $0.34 dividend for Q4 and authorized $50M in share repurchases.
Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ
Crescent Capital BDC (CCAP) will release its Q3 2026 financial results on Nov. 9, 2026, after market close. A webcast to discuss the results is scheduled for Nov. 10, 2026, at 12:00 p.m. ET. The company is a business development company focused on middle market investments.
Analysts downgraded several stocks: Evercore ISI cut Chewy (CHWY) to In-Line with $25 target; Baird and B of A downgraded Cooper Companies (COO) to Neutral with targets $61 and $65; BMO downgraded Anglogold Ashanti (AU) to Market Perform; B of A cut Crescent Capital (CCAP) to Neutral with $10.25 target.
FIDELITY & GUARANTY LIFE INSURANCE CO sold 265,490 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.28 ($10.23–$10.33, $2.73M total) across 2 trades over 2026-09-08 to 2026-09-09 under a Rule 10b5-1 trading plan.
FIDELITY & GUARANTY LIFE INSURANCE CO sold 56,285 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.46 ($10.44–$10.50, $0.59M total) across 2 trades over 2026-09-01 to 2026-09-02 under a Rule 10b5-1 trading plan.
FIDELITY & GUARANTY LIFE INSURANCE CO sold 55,000 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.62 ($10.60–$10.62, $0.58M total) across 2 trades over 2026-08-28 to 2026-08-31 under a Rule 10b5-1 trading plan.
FIDELITY & GUARANTY LIFE INSURANCE CO sold 59,286 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.60 ($10.60–$10.60, $0.63M total) across 2 trades over 2026-08-26 to 2026-08-27 under a Rule 10b5-1 trading plan.
Fidelity & Guaranty Life Insurance Co, a 10% owner of Crescent Capital BDC (CCAP), sold 73,457 shares of common stock in two transactions on 2026-08-24 and 2026-08-25. The sales, executed under a Rule 10b5-1 trading plan, were at average prices of $10.72–$10.80 per share, totaling approximately $788,000.
